Citalopram plus reboxetine in treatment-resistant obsessive-compulsive disorder

被引：7
|
作者：
Fontenelle, LF
Mendlowicz, MV
Miguel, EC
Versiani, M
机构：
[1] IPUB UFRJ, Inst Psychiat, Anxiety & Depress Res Program, Rio De Janeiro, Brazil
[2] IPUB UFRJ, Inst Psychiat, Ethics & Forens Psychiat Res Program, Rio De Janeiro, Brazil
[3] UFF, MSM, Dept Psychiat & Mental Hlth, Niteroi, RJ, Brazil
[4] USP, Sch Med, Obsess Compuls Spectrum Disorders Clin PROTOG, Dept Psychiat, BR-09500900 Sao Paulo, Brazil
来源：
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY | 2005年 / 6卷 / 01期
关键词：
obsessive-compulsive disorder; citalopram; reboxetine;
D O I：
10.1080/15622970510029740
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
While serotonin reuptake inhibitors (SRIs) are the first-line treatment of obsessive-compulsive disorder (OCD), as many as 40-60% of patients fail to respond to adequate trials with these drugs. In this study, we describe the case of a patient with an SRI-resistant OCD who was successfully treated with a combination of citalopram (a selective SRI) and reboxetine (a selective noradrenaline reuptake inhibitor (SNRI)). This report suggests that future studies accessing the efficacy of the SRI-SNRI combination in treatment resistant OCD are needed.
引用
收藏
页码：57 / 59
页数：3
相关论文
共 50 条
  • [1] Citalopram for treatment-resistant obsessive-compulsive disorder
    Pallanti, S
    Quercioli, L
    Paiva, RS
    Koran, LM
    [J]. EUROPEAN PSYCHIATRY, 1999, 14 (02) : 101 - 106
  • [2] Response to high doses of citalopram in treatment-resistant obsessive-compulsive disorder
    Bejerot, S
    Bodlund, O
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1998, 98 (05) : 423 - 424
  • [3] Treatment-resistant obsessive-compulsive disorder
    Pallanti, S.
    Bernardi, S.
    Castellini, G.
    Quercioli, L.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S209 - S209
  • [4] Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder
    Hollander, E
    Dell'Osso, B
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (03) : 189 - 191
  • [5] Venlafaxine in treatment-resistant obsessive-compulsive disorder
    Hollander, E
    Friedberg, J
    Wasserman, S
    Allen, A
    Birnbaum, M
    Koran, LM
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (05) : 546 - 550
  • [6] Quetiapine in treatment-resistant obsessive-compulsive disorder
    Cohen, LS
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2003, 42 (06): : 623 - 624
  • [7] Management of Treatment-Resistant Obsessive-Compulsive Disorder
    Gershkovich M.
    Wheaton M.G.
    Simpson H.B.
    [J]. Current Treatment Options in Psychiatry, 2017, 4 (4) : 357 - 370
  • [8] Pharmacotherapy for Treatment-Resistant Obsessive-Compulsive Disorder
    Kayser, Reilly R.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (05)
  • [9] Venlafaxine in treatment-resistant obsessive-compulsive disorder
    Hollander, E
    Friedberg, J
    Wasserman, S
    Allen, A
    Koran, LM
    Birnbaum, M
    [J]. BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 206S - 207S
  • [10] Citalopram plus reboxetine in treatment-resistant depression
    Devarajan, S
    Dursun, SM
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2000, 45 (05): : 489 - 490
12345